* Meta-terms correspond to biological or medical specialty concerned with one or more keywords (or keywords hierarchies), qualifiers, or resource types. Other terms also benefit from this structure, when the topic warrants it, eg education. See the list.

Doc'CISMeF search for this specility :


Preferred Label : metabolism;

True Meta (CISMeF) : O;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/sel-de-fer-injectable
2025
false
false
false
France
French
risk management
iron compounds
iron, parenteral preparations
patient education handout
guidelines for drug use
injections, intravenous
infusions, intravenous
iron compounds
anaphylaxis
drug hypersensitivity
Drug-Related side effects and adverse reactions

---
https://publications.msss.gouv.qc.ca/msss/document-001617/
2025
false
false
false
Canada
pneumonia, viral
coronavirus infections
scientific and technical information
Population Forecast
Respect
population
coronavirus, nos
projection
coronavirus
appraiser
homing behavior
projection
population
projection
pandemics
COVID-19

---
https://www.chu-lyon.fr/education-therapeutique-et-mucoviscidose-age-adulte
2025
France
popular works
age, nos
education
patient education as topic
therapeutics
cystic fibrosis
adulthood
adult
aged
cystic fibrosis

---
https://www.has-sante.fr/jcms/p_3576423/fr/pheburane-phenylbutyrate-de-sodium-desordres-du-cycle-de-l-uree
2025
false
false
false
France
pharmaceutical solutions
administration, oral
treatment outcome
insurance, health, reimbursement
sodium phenylbutyrate
4-phenylbutyric acid
carbamoyl-phosphate synthase i deficiency disease
citrullinemia
ornithine carbamoyltransferase deficiency disease
evaluation of the transparency committee
phenylbutyrates
4-phenylbutyric acid, sodium salt

---
https://www.has-sante.fr/jcms/p_3568304/fr/biatain-silicone-forme-standard
2025
France
health technology assessment
reference standards
silicone
absorption
silicones
telephone switchboard operator
bandages
dressings

---
https://www.chu-lyon.fr/deficit-en-alpha-1-antitrypsine-aat
2025
France
popular works
alpha 1-Antitrypsin
aortic aneurysm, thoracic
alpha 1-antitrypsin deficiency
alpha-1-antitrypsin deficiency

---
https://www.chu-lyon.fr/maladie-de-wilson-et-autres-maladies-rares-liees-au-cuivre
2025
France
popular works
copper
wilson's disease
copper, nos
disease, nos
rare diseases
hepatolenticular degeneration

---
https://www.chu-lyon.fr/osteoporose
2025
France
popular works
osteoporosis, nos
osteoporosis
osteoporosis

---
https://www.santepubliquefrance.fr/determinants-de-sante/pollution-et-sante/air/documents/enquetes-etudes/estimation-de-la-morbidite-attribuable-a-l-exposition-a-long-terme-a-la-pollution-de-l-air-ambiant-et-de-ses-impacts-economiques-en-france-hexagona
2025
France
technical report
appraiser
Respect
morbidity
french
air pollution
air pollution
cost savings
quantitative evaluation
evaluation studies as topic
Exhibition
air pollution, indoor
exposure to pollution, nos
economics
france
health impact assessment

---
https://www.santepubliquefrance.fr/determinants-de-sante/pollution-et-sante/air/documents/enquetes-etudes/estimation-de-la-morbidite-attribuable-a-l-exposition-a-long-terme-a-la-pollution-de-l-air-ambiant-et-de-ses-impacts-economiques-en-france-hexagona2
2025
France
technical report
Economic Evaluation
france
Exhibition
air pollution
exposure to pollution, nos
french
air pollution
costs and cost analysis
appraiser
air pollution, indoor
Respect
morbidity

---
https://www.santepubliquefrance.fr/regions/auvergne-rhone-alpes/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-auvergne-rhone-alpes
2025
France
technical report
Air Quality
quality improvement
health
appraiser
air, nos
Respect
air pollution, indoor

---
https://www.santepubliquefrance.fr/regions/bourgogne-franche-comte/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-bourgogne-franche-comte
2025
France
technical report
air, nos
air pollution, indoor
quality improvement
health
Air Quality
Respect
appraiser

---
https://www.santepubliquefrance.fr/regions/bretagne/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-bretagne
2025
France
technical report
health
appraiser
Respect
air pollution, indoor
air, nos
quality improvement
Air Quality

---
https://www.santepubliquefrance.fr/regions/centre-val-de-loire/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-centre-val-de-loire
2025
France
technical report
Air Quality
quality improvement
air, nos
Respect
air pollution, indoor
health
central
valine
appraiser

---
https://www.santepubliquefrance.fr/regions/grand-est/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-grand-est
2025
France
technical report
appraiser
Air Quality
prion diseases
health
air pollution, indoor
Respect
quality improvement
air, nos

---
https://www.santepubliquefrance.fr/regions/hauts-de-france/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-hauts-de-france
2025
France
technical report
Air Quality
appraiser
Respect
health
air pollution, indoor
air, nos
quality improvement
france
french

---
https://www.santepubliquefrance.fr/regions/normandie/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-normandie
2025
France
technical report
health
air pollution, indoor
Air Quality
appraiser
air, nos
quality improvement
Respect

---
https://www.santepubliquefrance.fr/regions/nouvelle-aquitaine/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-nouvelle-aquitaine
2025
France
technical report
Air Quality
health
air, nos
quality improvement
air pollution, indoor
Respect
appraiser

---
https://www.santepubliquefrance.fr/regions/occitanie/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-occitanie
2025
France
technical report
Respect
appraiser
quality improvement
air, nos
health
Air Quality
air pollution, indoor

---
https://www.santepubliquefrance.fr/regions/pays-de-la-loire/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-pays-de-la-loire
2025
France
technical report
quality improvement
appraiser
air pollution, indoor
Respect
Air Quality
air, nos
health

---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-corse
2025
France
technical report
appraiser
air pollution, indoor
corsica
Air Quality
Respect
france
health
quality improvement
air, nos

---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-provence-alpes-cote-d-azur
2025
France
technical report
quality improvement
air pollution, indoor
health
appraiser
air, nos
unilateral
Respect
ribs
Air Quality

---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_4.html
2025
France
journal article
malignant neoplasm colon/rectum
Respect
france
french
Colorectal Cancer
insurance coverage
colorectal neoplasms
early detection of cancer
screening for cancer
cancer screening
appraiser

---
https://www.has-sante.fr/jcms/p_3578969/fr/suprasorb-p-sensitive-heel
2025
France
health technology assessment
bandages
dressings
absorption

---
https://www.has-sante.fr/jcms/p_3589534/fr/skyclarys-omaveloxolone-traitement-de-l-ataxie-de-friedreich-af
2025
false
false
false
France
omaveloxolone
evaluation of the transparency committee
friedreich's ataxia
Omaveloxolone
Omaveloxolone
friedreich ataxia

---
https://ansm.sante.fr/tableau-marr/cerliponase-alfa
2025
false
false
false
France
French
guidelines for drug use
risk management
cerliponase alfa
cerliponase alfa
infusions, intracerebroventricular
Movement of device from original site
Device related infection
Device occlusion
infusions, intracerebroventricular

---
https://ansm.sante.fr/tableau-marr/denosumab-1
2025
false
false
false
France
French
risk management
Denosumab
denosumab
Drug-Related side effects and adverse reactions
patient education handout
drug information
osteonecrosis
jaw diseases
Osteonecrosis of Jaw

---
https://www.has-sante.fr/jcms/p_3590908/fr/chlorure-de-sodium-aguettant-chlorure-de-sodium-solute
2025
false
false
false
France
evaluation of the transparency committee
solutions
urine chloride
sodium chloride
sodium chloride
solution, nos

---
https://www.has-sante.fr/jcms/p_3592928/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine-avec-cardiomyopathie
2025
false
false
false
France
amyloid neuropathies, familial
evaluation of the transparency committee
amylose
amyloidosis, hereditary, Transthyretin-Related
cardiomyopathies

---
https://www.inserm.fr/dossier/diabete-type-2/
2025
France
popular works
diabetes mellitus, type 2
diabetes non-insulin dependent
metabolism
life style
life style, nos
metabolic disease, nos

---
https://www.sfed.org/non-classe/replays-de-la-journee-de-lendoscopie-bariatrique-et-metabolique-jebem/
2025
France
congresses
endoscopy, nos
bariatrics
general metabolic function, nos
metabolism
endoscopy

---
https://www.cochrane.org/fr/CD015849/CENTRALED_le-traitement-par-agonistes-des-recepteurs-du-glp-1-previent-il-les-complications-chez-les-personnes
2025
United Kingdom
review of literature
french abstract
renal insufficiency, chronic
kidney diseases
diabetes with renal manifestations
Glucagon-Like Peptide-1 Receptor
diabetic complications
glucagon-like peptide 1
chronic disease
chronic disease, nos
kidney disease, nos
receptors, interleukin-1
diabetes complications
diabetic nephropathies
persons

---
https://www.has-sante.fr/jcms/p_3599704/fr/ferrostrane-nourrissons-feredetate-de-sodium-carence-martiale
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
pharmaceutical solutions
administration, oral
sodium feredetate
evaluation of the transparency committee
Iron Deficiencies
ferric sodium edetate
infant
Fe(III)-EDTA

---
https://www.ineris.fr/fr/chlorure-ethylene
2025
France
scientific and technical information
ethylene
ethylene
chloride salt, nos
chlorination
chlorides
urine chloride
ethylene dichloride
halogenation
ethylenes

---
https://www.cochrane.org/fr/CD016039/CENTRALED_les-antibiotiques-peuvent-ils-controler-ou-eradiquer-linfection-par-des-mycobacteries-non
2025
United Kingdom
review of literature
french abstract
uncontrolled
cystic fibrosis
antibiotic, nos
tuber, nos
persons
mycobacterium, nos
disease
antibiotics
mycobacterium infections, nontuberculous
lung
infection control
anti-bacterial agents
infectious disease, nos
cystic fibrosis

---
https://www.has-sante.fr/jcms/p_3431851/fr/xenpozyme-olipudase-alfa-deficit-en-sphingomyelinase-acide
2025
false
false
false
France
evaluation of the transparency committee
sphingomyelin/cholesterol lipidosis, nos
xenpozyme
acid, nos
olipudase alfa
niemann-pick diseases
olipudase alfa

---
https://ansm.sante.fr/tableau-marr/eliglustat
2025
false
false
false
France
French
risk management
eliglustat
guidelines for drug use
drug interactions
patients guideline
eliglustat

---
https://ansm.sante.fr/tableau-marr/lomitapide
2025
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral

---
https://ansm.sante.fr/tableau-acces-derogatoire/xenpozyme#
2025
false
false
false
France
French
drug information
olipudase alfa
olipudase alfa
enzyme replacement therapy
child
adolescent
adult
niemann-pick diseases

---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2025
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency
technical report

---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2025
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec

---
http://beh.santepubliquefrance.fr/beh/2025/1/2025_1_1.html
2025
France
journal article
appraiser
Vaccination Coverage
Balance Sheet
school health services
Respect
scales
weights and measures
ladder, nos
health
feasibility studies
due to

---
https://ansm.sante.fr/actualites/vitamine-b12-injectable-et-buvable-preferez-les-comprimes-aux-ampoules-pour-lusage-par-voie-orale
2024
false
false
false
France
French
drug information
guideline
injections, intramuscular
administration, oral
vitamin B 12
Malabsorption of Vitamin B12
vitamin b 12 deficiency
cyanocobalamin
-
-

---
https://www.reiso.org/articles/themes/soins/13111-socio-esthetique-redonner-corps-a-l-estime-de-soi
2024
Switzerland
popular works
self concept
self esteem
body parts
appraiser
human body

---
https://www.has-sante.fr/jcms/p_3542845/fr/skyclarys-omaveloxolone-ataxie-de-friedreich
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
adolescent
administration, oral
orphan drug production
omaveloxolone
evaluation of the transparency committee
friedreich ataxia
Omaveloxolone

---
https://www.academie-medecine.fr/changement-de-paradigme-dans-les-maladies-cardio-nephro-metaboliques/
2024
France
technical report
metabolic disease, nos
metabolic diseases
nephrology
changing

---
https://www.has-sante.fr/jcms/p_3542916/fr/rachitismes-rares-vitamine-d-dependants
2024
France
practice guideline
behavior, addictive
Handbook
chronic disease, nos
rare diseases
chronic disease
vitamin D
vitamin d-dependent rickets, nos
rickets
Dependency, Psychological

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2024-50/numero-9-septembre-2024/estimation-risques-sante-publique-lies-maladies-infectieuses.html
2024
Canada
journal article
appraiser
disease
evaluation studies as topic
public health
communicable diseases
infectious disease, nos
hazardous substances
infectious diseases
risk assessment

---
https://minerva-ebp.be/FR/Article/2401
2024
Belgium
critical appraisal or critical reading
diet
dietary supplements
iron, nos
diet, nos
absorption
eating
iron, dietary

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024010/article/00001-fra.htm
2024
Canada
journal article
devices
blood pressure, nos
appraiser
equipment and supplies
adulthood
adult
arterial pressure
hypertension
automatism
device, nos
robot
measures
incidence
population
hypertensive disease, nos
automatism
Respect
Set, Psychology
weights and measures
breast

---
https://minerva-ebp.be/FR/Analysis/882
2024
Belgium
critical appraisal or critical reading
prediabetic state
prediabetes
longterm effects
life style, nos
life style
persons

---
https://www.has-sante.fr/jcms/p_3554673/fr/nexviadyme-avalglucosidase-alfa-maladie-de-pompe
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Avalglucosidase Alfa
avalglucosidase alfa
enzyme replacement therapy
guidelines for drug use
evaluation of the transparency committee
glycogen storage disease type ii

---
https://www.has-sante.fr/jcms/p_3550922/fr/crysvita-burosumab-maladie-osseuse
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
burosumab
FGF23-related hypophosphataemia
hypophosphatemia
X-linked hypophosphatemia
child
adolescent
adult
Oncogenic hypophosphatemic osteomalacia
Phosphaturic Mesenchymal Tumor
evaluation of the transparency committee
burosumab
bone diseases

---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense

---
https://www.has-sante.fr/jcms/p_3487175/fr/resposorb-silicone-border
2024
France
health technology assessment
Packing Dosage Form
Energy Absorption
Biological Absorption
Medical Packing
Pharmacokinetics: Absorption
anatomists
silicones
Dressing Dosing Unit
Importer
anatomy
dressing, nos
Anatomic Border
Dressing
bandages
absorption
anatomist
Import
Biomedical Packing Material
silicone
Silicone

---
https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose
2024
false
false
false
France
infant
child
evaluation of the transparency committee
ivacaftor
cystic fibrosis
ivacaftor
Ivacaftor
Cystic Fibrosis
cystic fibrosis
kalydeco
ivacaftor

---
https://www.santepubliquefrance.fr/docs/priorisation-des-couples-maladie-facteur-de-risque-pour-l-estimation-du-fardeau-environnemental-et-professionnel-de-la-maladie-en-france
2024
false
false
false
France
technical report
Health Care Professional Promotional Material
Risk Estimate
appraiser
Disease Steps Clinical Classification
france
tularemia
CHFR Gene
family characteristics
risk factors
tularemia, nos
Professional Occupation
environmental illness
risk factor
couples
risk assessment
Couple
Disease Free
Environmental Risk Factor
Disease Object
cost of illness
occupational diseases
hazardous substances
Coupler Device
Burden
No Evidence of Coronary Artery Disease

---
https://www.has-sante.fr/jcms/p_3490824/fr/crysvita-burosumab-hypophosphatemie-liee-a-l-x
2024
false
false
false
France
child
adolescent
treatment outcome
insurance, health, reimbursement
rickets, X-Linked hypophosphatemic
burosumab
injections, subcutaneous
antibodies, monoclonal, humanized
evaluation of the transparency committee
burosumab
familial hypophosphatemic rickets
X-Linked Dominant Hypophosphatemic Rickets

---
https://www.has-sante.fr/jcms/p_3478085/fr/liporosa-rosuvastatine/ezetimibe-maladie-coronaire-avec-antecedent-de-syndrome-coronarien-aigu-sca
2024
false
false
false
France
evaluation of the transparency committee
Coronary
high pitch
Superior Cerebellar Artery
Disease Object
Acute Coronary Syndrome
disease
coronary disease
Disease Steps Clinical Classification
disease, nos
No Evidence of Coronary Artery Disease
case histories
Disease Free
acute coronary syndrome

---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous

---
https://www.has-sante.fr/jcms/p_3426280/fr/depistage-neonatal-reevaluation-de-l-opportunite-d-integrer-cinq-erreurs-innees-du-metabolisme-au-programme-de-dnn
2024
France
public health guidelines
Newborn Screening
Schedule
metabolic disease, nos
Integrator Device
Integrated
neonatal screening, nos
metabolism, inborn errors
neonatal screening
Severity One Out of Five
Congenital Metabolic Disorder
Scheduled
Metabolic Programming

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-de-lajout-du-depistage-neonatal-de-lhyperplasie-congenitale-des-surrenales-au-programme-quebecois-de-depistage-neonatal-sanguin.html
2024
Canada
review of literature
public health guidelines
Add
Attention Deficit Hyperactivity Disorder, Inattentive Type
Schedule
congenital adrenal cortical hyperplasia, nos
adrenal hyperplasia, congenital
Program
neonatal screening, nos
Newborn Screening
neonatal screening
Congenital Adrenal Hyperplasia
Blood Screening
Scheduled

---
https://ansm.sante.fr/tableau-marr/olipudase-alfa
2024
false
false
false
France
French
guidelines for drug use
popular works
risk management
olipudase alfa
olipudase alfa
Drug-Related side effects and adverse reactions
infusions, intravenous
home infusion therapy
Infusion-Related Reaction
drug hypersensitivity
anaphylaxis
olipudase alfa

---
https://publications.msss.gouv.qc.ca/msss/document-003344/
2024
false
false
false
Canada
handbooks
hereditary diseases
Diseases
metabolic diseases
metabolism, inborn errors
Metabolic diseases
Hereditary disease
Metabolic diseases
Metabolic diseases
metabolic disease, nos
Program
hereditary disease, nos
waiting lists

---
https://www.has-sante.fr/jcms/p_3577018/fr/lamzede-velmanase-alfa-alpha-mannosidose
2024
false
false
false
France
evaluation of the transparency committee
mannosidosis, nos
temperance
Mannosidosis
alpha-Mannosidosis

---
https://ansm.sante.fr/tableau-marr/insuline-degludec
2024
false
false
false
France
French
risk management
insulin degludec
medication errors
guidelines for drug use
injections, subcutaneous
insulin degludec
patient education handout
hypoglycemic agents
guideline
insulin, long-acting

---
https://ansm.sante.fr/tableau-marr/insuline-glargine
2024
false
false
false
France
French
Insulin Glargine
medication errors
risk management
insulin glargine
guidelines for drug use
patients guideline

---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-liees-au-travail/troubles-musculo-squelettiques/documents/enquetes-etudes/programme-de-surveillance-des-maladies-a-caractere-professionnel.-estimation-de-la-sous-declaration-des-troubles-musculo-squelettiques-tms-chez-l
2024
France
journal article
character
Program
france
transcranial magnetic stimulation
Respect
musculoskeletal diseases
disease, nos
occupational musculoskeletal disorders
occupational diseases
skeletal system, nos
registries
appraiser
skeleton
french

---
https://www.anses.fr/fr/content/evaluer-toxicite-substances-metabolisme
2024
France
popular works
general metabolic function, nos
toxic effect
evaluation studies as topic
metabolism

---
https://www.cochrane.org/fr/CD012718/ORAL_le-vernis-au-fluorure-de-diamine-dargent-est-il-un-traitement-efficace-pour-prevenir-et-traiter-la
2024
United Kingdom
review of literature
french abstract
silver fluoride
diamines
varnish
silver fluoride
silver fluoride
dental caries
child, nos
dental caries, nos
adulthood
paint
child
urinary fluoride level
attentiveness
silver
halogenation
fluorides
adult children
adult
varnish

---
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/FICHE%20PRATIQUE_EKFC%20iohexol_d%C3%A9cembre%202024.pdf
https://www.sfndt.org/sites/www.sfndt.org/files/medias/documents/FIGURE%20EKFC.pdf
2024
France
scientific and technical information
iohexol
metabolic clearance rate
consensus
reference standards

---
https://www.has-sante.fr/jcms/p_3571320/fr/brineura-cerliponase-alfa-maladie-rare
2024
false
false
false
France
evaluation of the transparency committee
cerliponase alfa
cerliponase alfa
disease, nos
Brineura
rare diseases

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-du-statut-de-phosphorylation-de-stat3-par-cytometrie-en-flux.html
2024
Canada
health technology assessment
phosphorylation
flow cytometry
evaluation studies as topic
flow cytometry, nos

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-du-statut-de-phosphorylation-de-stat5-par-cytometrie-en-flux.html
2024
Canada
health technology assessment
flow cytometry, nos
phosphorylation
flow cytometry
evaluation studies as topic

---
https://ansm.sante.fr/tableau-marr/acide-cholique
2024
false
false
false
France
French
cholic acid
risk management
guideline
cholic acid
administration, oral
bile acid synthesis defect, congenital, 2
bile acid synthesis defect, congenital, 1
signs and symptoms
drug information
bile acid synthesis defect, congenital, 2
bile acid synthesis defect, congenital, 1

---
https://ansm.sante.fr/tableau-marr/agalsidase-alpha
2024
false
false
false
France
French
risk management
agalsidase alfa
agalsidase alfa
infusions, intravenous
guidelines for drug use
patients guideline
continuity of patient care
drug hypersensitivity
self administration

---
https://ansm.sante.fr/tableau-marr/laronidase
2024
false
false
false
France
French
risk management
Laronidase
infusions, intravenous
drug hypersensitivity
home nursing
guidelines for drug use
patients guideline
laronidase
home infusion therapy
Infusion-Related Reaction

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024012/article/00002-fra.htm
2024
Canada
journal article
automatism
equipment and supplies
blood pressure, nos
appraiser
measures
child
automatism
Set, Psychology
Respect
weights and measures
child, nos
arterial pressure
adolescent
robot
devices
incidence
arteries
device, nos

---
https://www.chu-lyon.fr/hyperplasie-congenitale-des-surrenales
2024
France
patient education handout
adrenal hyperplasia, congenital
Hypotonia-Cystinuria syndrome
congenital adrenal cortical hyperplasia, nos

---
https://www.chu-lyon.fr/amylose-al
2024
France
popular works
amylose
amyloid deposition, nos
Immunoglobulin Light-chain Amyloidosis
amyloidosis, nos

---
https://www.chu-lyon.fr/diabete-ou-diabete-sucre
2024
France
popular works
diabetes mellitus, nos
diabetes mellitus

---
https://www.chu-lyon.fr/goutte
2024
France
popular works
gout, nos
guttate
gout
gout

---
https://www.has-sante.fr/jcms/p_3449778/fr/crysvita-burosumab-hypophosphatemie-liee-au-fgf23
2024
false
false
false
France
French
evaluation of the transparency committee
burosumab

---
http://beh.santepubliquefrance.fr/beh/2024/5/2024_5_1.html
2024
France
journal article
Convenient
france
French Language
Program
french
Screening for Colorectal Cancer
organization
cancer screening
Schedule
malignant neoplasm colon/rectum
screening for cancer
early detection of cancer
French Catheter Gauge
Organization
Participation
Respect
Scheduled
Colorectal Cancer
Version
appraiser
colorectal neoplasms
mass screening
Estimate
Statistical Estimation

---
https://www.has-sante.fr/jcms/p_3498146/fr/myozyme-alglucosidase-alfa-maladie-de-pompe-deficit-en-glucosidase-acide
2024
false
false
false
France
GAA protein, human
adult
adolescent
child
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
infusions, intravenous
alglucosidase alfa
glycogen storage disease type II, infantile
adult glycogen storage disease type II
Glycogen storage disease type II late onset (disorder)
evaluation of the transparency committee
glycogen storage disease type ii
alglucosidase alfa

---
https://www.inspq.qc.ca/publications/3464
2024
Canada
technical report
Respect
appraiser
reticulum
COVID-19
population
Amplifier Device
Evaluation Method
General Population
COVID-19 Infection
Number of Cases
protestantism
Estimate
amplifiers, electronic
quebec
snacks
general practitioners
Enhancer
Statistical Estimation
Device Evaluation Method
evaluation studies as topic

---
https://www.has-sante.fr/jcms/p_3499781/fr/ferinject-carboxymaltose-ferrique-carence-martiale
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
iron, parenteral preparations
injections, intravenous
infusions, intravenous
ferric carboxymaltose
ferric compounds
Iron Deficiencies
evaluation of the transparency committee

---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2024003/article/00001-fra.htm
2024
Canada
technical report
CDISC SDTM Submission Domain Abbreviation Terminology
residence characteristics
Story
health
Submission Domain
Correlation
Rating Myself
Respect
Individual
community
Use
Self-Assessment
Person
appraiser
Self Assessment
Self-Report
Estimate
Statistical Estimation
SANT Domain

---
Ezetrol (ezetimibe) and the Risks of Drug-Induced Liver Injury and Severe Cutaneous Adverse Reactions
https://recalls-rappels.canada.ca/fr/avis-rappel/ezetrol-ezetimibe-et-risques-lesions-hepatiques-origine-medicamenteuse-et-reactions
2024
false
false
false
Canada
French
English
pharmacovigilance note
Ezetimibe
Chemical and Drug Induced Liver Injury
Drug-Induced Liver Disease
drug hypersensitivity syndrome
stevens-johnson syndrome
epidermal necrolysis, toxic
Drug-Induced stevens johnson syndrome
canada
administration, oral
ezetimibe
anticholesteremic agents

---
https://www.has-sante.fr/jcms/p_3502273/fr/polystyrene-sulfonate-de-sodium-substipharm-polystyrene-sulfonate-de-sodium-hyperkaliemie
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
hyperkalemia
chelating agents
administration, oral
administration, rectal
polystyrene sulfonate
evaluation of the transparency committee
polystyrene sulfonic acid
polystyrenes
polystyrene sulfonic acid, homopolymer, sodium salt

---
https://www.has-sante.fr/jcms/p_3505740/fr/lojuxta-lomitapide-hypercholesterolemie-familiale-homozygote
2024
false
false
false
France
Lomitapide Mesylate
Homozygous Familial Hypercholesterolemia
child
adolescent
evaluation of the transparency committee
lomitapide
Lomitapide Mesylate
mesylates

---
https://www.has-sante.fr/jcms/p_3506440/fr/repatha-evolocumab-hypercholesterolemie
2024
false
false
false
France
evaluation of the transparency committee
repatha
Hypercholesterolemia
hypercholesterolemia
evolocumab
Evolocumab
evolocumab
hypercholesterolemia, nos

---
https://www.has-sante.fr/jcms/p_3508486/fr/uvedose-cholecalciferol-carence-en-vitamine-d
2024
false
false
false
France
evaluation of the transparency committee
Vitamin D3
vitamin d deficiency, nos
Vitamin D3 Measurement
Vitamin D Deficiency
vitamin d deficiency
Cholecalciferol
vitamin d3
cholecalciferol

---
https://www.has-sante.fr/jcms/p_3509116/fr/junaliza-atorvastatine/ezetimibe-hypolipidemiants-en-association
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Ezetimibe
Atorvastatin
atorvastatin calcium
atorvastatin and ezetimibe
hypercholesterolemia
non-familial primary hypercholesterolemia
Familial hypercholesterolemia - heterozygous (disorder)
Mixed Hyperlipidemia
adult
evaluation of the transparency committee
drug combinations
hypolipidemic agents

---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101204/n/exposition-professionnelle-femmes-substances-chimiques
2024
Canada
technical report
effects of exposure to external cause, nos
Specified
Chemical Exposure
C-C Motif Chemokine 7
Matrix Device
Substance
Fogarty International Center
Be
Enhance
Gender
employment
specific
CDISC SDTM Sex of Individual Terminology
unemployment
sex ratio
Ratio
templates, genetic
albumin/globulin ratio
Improved
Designated
extracellular matrix
occupational exposure
sex
women
GDC Gender Terminology
Regulatory Report
Statistical Estimation
Matrix Dosing Unit
Unemployed
CCL7 wt Allele
Provide
Occupational Exposure
Respect
Abstracting
Fentanyl
appraiser
Designated Blood Product Donation
Estimate
Woman

---
https://www.has-sante.fr/jcms/p_3515714/fr/lokelma-cyclosilicate-de-zirconium-sodique-hyperkaliemie
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
sodium zirconium cyclosilicate
hyperkalemia
adult
ion exchange resins
administration, oral
evaluation of the transparency committee
sodium zirconium cyclosilicate
Lokelma

---
https://www.has-sante.fr/jcms/p_3516966/fr/loargys-pegzilarginase-deficit-en-arginase-1
2024
false
false
false
France
ARG1 protein, human
insurance, health, reimbursement
treatment outcome
orphan drug production
package leaflet
summary of product characteristics
adult
pegzilarginase
adolescent
child
guidelines for drug use
enzyme replacement therapy
continuity of patient care
evaluation of the transparency committee
hyperargininemia
Arginase-1
Pegzilarginase

---
https://www.ema.europa.eu/en/medicines/human/EPAR/loargys
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Pegzilarginase
Pegzilarginase
pegzilarginase
enzyme replacement therapy
drug approval
europe
hyperargininemia
orphan drug production
child
adolescent
adult
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
infusions, intravenous
injections, subcutaneous

---
https://www.cochrane.org/fr/CD006257/RENAL_inhibiteurs-de-lenzyme-de-conversion-de-langiotensine-et-antagonistes-des-recepteurs-de
2024
United Kingdom
review of literature
french abstract
Progression
Upon Progression
diabetic nephropathies
angiotensin receptor site
Diabetic Nephropathy
angiotensin-converting enzyme inhibitor agent, nos
Receptor
Preventive Intervention
ACE Inhibitor
Prevention
angiotensin-converting enzyme inhibitors
angiotensin receptor antagonists
Prevention Study
Cancer Progression

---
https://www.usherbrooke.ca/baladocritique/archives/episode-61-etude-maestro-nash
2024
Canada
sound
episode of
metabolism
Therapy Object
Biomaterial Treatment
Treatment Study
Episode
Metabolic Abnormality Assessment
Treat
No Treatment for Diabetes
functional disorder, nos
Nonalcoholic Steatohepatitis
general metabolic function, nos
Resmetirom
Pathophysiology
During Treatment
Treatment
GDC Treatment Frequency Terminology
On Treatment
data collection
steatohepatitis
Non-alcoholic Fatty Liver Disease
Dysfunction
Nonalcoholic Steatohepatitis
Treatment Epoch

---
https://ansm.sante.fr/tableau-acces-derogatoire/onpattro
2024
false
false
false
France
French
patisiran
drug information
guidelines for drug use
infusions, intravenous
Wild type ATTR amyloidosis
Hereditary ATTR amyloidosis
Cardiac ATTR Amyloidosis
amyloidosis
Transthyretin

---
https://www.has-sante.fr/jcms/p_3518649/fr/ilaris-canakinumab-crise-d-arthrite-goutteuse
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Acute gout (disorder)
canakinumab
injections, subcutaneous
evaluation of the transparency committee
canakinumab
arthritis, gouty

---
https://pap-pediatrie.fr/metabolisme/acidose-metabolique-chez-lenfant
2024
France
scientific and technical information
algorithms
child, nos
Child Individual
child
Metabolic Acidosis
metabolic acidosis, nos
acidosis
Child Relation
metabolic acidosis

---
https://www.rheuma-net.ch/fr/doc/osteoporose-cortisonique-prevention-et-traitement/viewdocument/366
2024
Switzerland
algorithms
cortisone
osteoporosis, nos
Treatment Study
Treat
On Treatment
Prevention
osteoporosis
During Treatment
Prevention Study
osteoporosis
Treatment
Preventive Intervention
cortisone
No Treatment for Diabetes
GDC Treatment Frequency Terminology
preventive treatment, nos
Cortisone
Treatment Epoch
Osteoporosis
Therapy Object
Biomaterial Treatment

---
https://www.santepubliquefrance.fr/etudes-et-enquetes/ester-enquete-de-sante-percue-qualite-de-vie-environnement-dans-les-territoires-de-la-region-grand-est
https://www.estergrandest.fr/
2024
France
scientific and technical information
Largest
Iceland
Estonia
Surrounding
Environmental
quality of life
esterification
Organic Ester
DNA Insertion Elements
Approximate
Expressed Sequence Tag
International Scale for BCR-ABL1 Measurement
homing behavior
East
health surveys
Clinical Trial Registry Identifier
detective
prion diseases
Eastern Standard Time
Immunogenicity Specimen Assessments Domain
esters
Canine Quality of Life Survey
SULT1E1 wt Allele
Greater
ester, nos
environment
Large
MAP3K8 wt Allele

---
https://www.cochrane.org/fr/CD009530/CF_utilisation-dechantillons-obtenus-par-bronchoscopie-pour-decider-comment-traiter-les-infections
2024
United Kingdom
review of literature
french abstract
People
bronchoscopy
persons
Bronchoscopy
Infectious Lung Disorder
cystic fibrosis
Cystic Fibrosis
Infections
specimen processing, nos
pulmonary cystic fibrosis
cystic fibrosis of the lung
Specimen Processing
infectious disease, nos
medical waste disposal
bronchoscopy, nos
disease
Use

---
https://www.cbip.be/fr/articles/4344?folia=4336
2024
false
false
false
Belgium
French
journal article
pharmacovigilance note
Denosumab
hypocalcemia
denosumab
renal insufficiency

---
https://www.ema.europa.eu/en/medicines/human/EPAR/skyclarys
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Omaveloxolone
Omaveloxolone
drug approval
europe
orphan drug production
friedreich ataxia
continuity of patient care
administration, oral
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
omaveloxolone

---
https://www.has-sante.fr/jcms/p_3521987/fr/praluent-alirocumab-hypercholesterolemie-familiale-heterozygote-chez-les-enfants-et-adolescents-a-partir-de-8-ans
2024
false
false
false
France
Familial hypercholesterolemia - heterozygous (disorder)
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
hypolipidemic agents
evaluation of the transparency committee
child
high serum cholesterol, familial
hyperlipoproteinemia type ii
adolescent
alirocumab

---
https://dumas.ccsd.cnrs.fr/dumas-04583193
2024
France
dissertations, academic
BCAR1 wt Allele
True Case Status
Subject Characteristics Original Result
French Catheter Gauge
Case
Vitamin C Deficiency
CTNND1 wt Allele
scurvy
Therapeutic
hospitals, proprietary
Therapeutic Procedure
No Cases Transmission Pattern
Childhood-Onset Systemic Lupus Erythematosus
Case Dosing Unit
Collection
Reviewing
Epidemiologic Study
Treatment
Pediatric
pediatrics
review literature as topic
ascorbic acid deficiency
Epidemiologic Study Characteristics
Epidemiology Research
therapeutics
Coronavirus Anxiety Scale
Catenin Delta-1
French Language
Pediatricians
Clinical Study
Clinical Study
Packaging Case
france
snacks
Pediatric
pediatrician
french
Breast Cancer Anti-Estrogen Resistance Protein 1

---
https://ansm.sante.fr/tableau-marr/acetate-de-chlormadinone
2024
false
true
false
France
French
risk management
meningioma
chlormadinone acetate
progesterone congeners
chlormadinone
drug information
patients guideline
continuity of patient care
mass screening
meningioma
risk

---
https://www.ce-mir.fr/files/medias/documents/35.%20Gaz%20du%20sang%20et%20troubles%20de%20l%27%C3%A9quilibre%20acidobasique.pdf
2024
France
educational course
blood
gas, nos
PAGR1 wt Allele
Hematopoietic and Lymphoid Cell Disorder
blood gas analysis
pH Homeostasis
GAST wt Allele
gases
disorder of balance, nos
acid-base imbalance

---
https://www.ce-mir.fr/files/medias/documents/36.%20%C3%89tiologie%20des%20anomalies%20gazom%C3%A9triques%20d%27origine%20m%C3%A9tabolique.pdf
2024
France
educational course
Abnormality
Molecular Genetic Variation
blood gas analysis
Metabolic Process
Abnormal Indicator
Metabolic
defect, nos
CDISC Define-XML Origin Source Terminology
metabolism
general metabolic function, nos

---
https://www.ce-mir.fr/files/medias/documents/37.%20D%C3%A9sordres%20hydro%C3%A9lectrolytiques%2C%20anomalies%20du%20bilan%20de%20l%27eau.pdf
2024
France
educational course
Drinking Water
uterine artery embolization
With Water
Abnormality
water-electrolyte imbalance
With Plenty of Water
Molecular Genetic Variation
Balance Sheet
Abnormal Indicator
water
defect, nos
Checkup
water

---
https://www.ce-mir.fr/files/medias/documents/38.%20D%C3%A9sordres%20hydro%C3%A9lectrolytiques%20-%20dyskali%C3%A9mie.pdf
2024
France
educational course
water-electrolyte imbalance

---
https://www.ce-mir.fr/files/medias/documents/39.%20Hypercalc%C3%A9mie%20aigu%C3%AB%20s%C3%A9v%C3%A8re.pdf
2024
France
educational course
Epidermal cGVHD Score 4
hypercalcemia
Hypercalcemia, CTCAE
Intensity and Distress 5
Severe Extremity Pain
Severe Hallucination
Severe Adverse Event
Borg Category-Ratio 10 Perceived Exertion Score 5
hypercalcemia
severe
Hypercalcemia
Severe Dysplasia

---
https://www.ce-mir.fr/files/medias/documents/40.%20Acidoc%C3%A9tose%20diab%C3%A9tique%20et%20%C3%A9tat%20hyperosmolaire.pdf
2024
France
educational course
US State
State Ownership
State
Status
Diabetic Ketoacidosis
diabetes with ketoacidosis
diabetic ketoacidosis

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/specificites-maladies-genetiques-propos-dune-maladie-genique-mucoviscidose
2024
France
educational course
Cystic Fibrosis
disease, nos
No Evidence of Coronary Artery Disease
sensitivity and specificity
cystic fibrosis
cystic fibrosis
genetics
Disease Steps Clinical Classification
Specificity of Diagnostic Test
disease
specificity
proband
Disease Free
Disease Object
Approximate
genets
Analyte Specificity
hereditary disease, nos

---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/endocrinologie-metabolisme/hypoglycemie
2024
France
educational course
hypoglycaemia
hypoglycemia
Hypoglycemia, CTCAE
hypoglycemia, nos
Hypoglycemia

---
https://www.reseau-naissance.fr/medias/2024/07/RSN-supplementation-vit-D-et-PEC-hypoca-2024.pdf
2024
France
guideline
Date of Diagnosis
health planning guidelines
Charge
diagnosis
hospitals, maternity
Diagnosis Code
Disease or Disorder
Newar Language
vitamin D
motherhood
no diagnosis
patient care management
Vitamin D Measurement
Hypocalcemia
Ergocalciferol
infant, newborn
hypocalcemia
newborn, nos
Nutritional Supplementation
hypocalcemia
New Lesion Identification
Diagnosis Study
vitamin d, nos
Human Papillomavirus-35
Thirty Five

---
https://www.has-sante.fr/jcms/p_3531241/fr/fora-6-duo-et-fora-6
2024
France
health technology assessment
Customize
device, nos
blood glucose
Smoking at Diagnosis
ketonemia
Six
Reading Ability
Thought Score 6
Sexual Maturity Status
ketonemia
Severity of Symptom Score 6
weights and measures
Measured Tumor Identification
automatism
Blood Glucose Measurement
Measurement
measures
ketosis
robot
CSF1R wt Allele
Fear Score 6
Apparatus
equipment and supplies
Blood Glucose
Clinical Status Ordinal Scale Outcome 6
automatism
Measurement
Automatic
Illness Intrusiveness Rating 6

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-du-statut-de-phosphorylation-de-stat1-par-cytometrie-en-flux.html
2024
Canada
technical report
Signal Transducer and Activator of Transcription 1-Alpha/Beta
Phosphorylation Site
flow cytometry, nos
STAT1 Gene
Physical Examination
flow cytometry
phosphorylation
Assessment
Assessment
Evaluation
Flow Cytometry
evaluation studies as topic

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/panel-des-maladies-mitochondriales-par-sequencage-de-nouvelle-generation.html
2024
Canada
technical report
family characteristics
disease, nos
Panel Device
generations
mitochondrial diseases
sequence analysis
Next Generation Sequencing
sequence determinations
Mitochondrion
mitochondrion, nos
Disease or Disorder

---
https://ansm.sante.fr/tableau-marr/pegzilarginase
2024
false
false
false
France
French
risk management
Pegzilarginase
pegzilarginase
drug information
patients guideline
medication errors
Pegzilarginase
drug hypersensitivity
injections, subcutaneous
home nursing

---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-praluent-300-mg-les-pharmaciens-peuvent-dispenser-une-boite-de-deux-stylos-preremplis-praluent-150-mg-en-remplacement-de-praluent-300-mg
2024
false
false
false
France
French
drug information
alirocumab
continuity of patient care
france
guideline
pharmacists
alirocumab
patient education handout

---
https://minerva-ebp.be/FR/Article/2393
2024
Belgium
critical appraisal or critical reading
vitamin D
vitamin d, nos
Prediabetes
What Month is it
Diabetes Mellitus
Prevention
Ergocalciferol
diabetes mellitus
Patient
Have Diabetes
Prevention Study
has patient
prediabetes
Vitamin D Measurement
Preventive Intervention
patients
prediabetic state
Diastolic Blood Pressure

---
https://www.canal-u.tv/chaines/univ-bordeaux/deficit-en-alpha-1-antitrypsine
2024
France
audiovisual aids
alpha 1-antitrypsin deficiency
alpha-1-antitrypsin deficiency
Alpha-1 Antitrypsin Deficiency

---
https://www.has-sante.fr/jcms/p_3535999/fr/freestyle-optium-neo-et-freestyle-optium-beta-cetone
2024
France
health technology assessment
robot
Ethiopia
ketonemia
Blood Glucose
Ketone
device, nos
Docetaxel/Epirubicin Regimen
Blood Glucose Measurement
blood glucose
Electrical Lead Device
EDNRB wt Allele
Automatic
ketone, nos
Endotracheal Route of Administration
NEO Gene
Reading Ability
Apparatus
Andorra
beta, nos
ketonemia
electrode, nos
ketosis
Essential Thrombocythemia
electrodes
Electrode Device
automatism
automatism
ketones
Formoterol Fumarate/Roxithromycin

---
https://ansm.sante.fr/actualites/analogues-du-glp-1-et-diabete-de-type-2-reprise-progressive-des-initiations-de-traitement-pour-ozempic-et-victoza
2024
false
false
false
France
French
patient education handout
guideline
drug information
Glucagon-Like Peptide-1 Receptor Agonists
diabetes mellitus, type 2
Glucagon-like peptide-1 (GLP-1) analogues
Pharmacotherapy Initiation
Pharmacotherapy Continuation
dulaglutide
semaglutide
Liraglutide

---
https://www.has-sante.fr/jcms/p_3539069/fr/ilaris-canakinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
canakinumab
injections, subcutaneous
chronic disease
biological therapy

---
https://www.has-sante.fr/jcms/p_3411728/fr/januvia-sitagliptine-diabete-de-type-2
2023
false
false
false
France
hypoglycemic agents
evaluation of the transparency committee
Sitagliptin Phosphate
diabetes mellitus, type 2

---
https://apps.who.int/iris/handle/10665/366169
2023
Switzerland
journal article
typhoid fever
Respect
scales
ladder, nos
achievement
Fever
vaccination
vaccines, conjugate
Vaccinia
Vaccins
weights and measures
organization and administration
vaccines, typhoid
appraiser
typhoid-paratyphoid vaccines
typhoid fever
preventive immunization/medication
fever
Typhoid
incidence
vision, ocular
vaccine, nos

---
https://ansm.sante.fr/actualites/risque-de-meningiome-et-progestatifs-recommandations-generales-pour-limiter-ce-risque
2023
false
false
false
France
French
guidelines for drug use
meningioma
progestins
Drug-Related side effects and adverse reactions
risk management
administration, oral
meningioma

---
https://www.santepubliquefrance.fr/determinants-de-sante/exposition-a-des-substances-chimiques/pesticides/documents/rapport-synthese/estimer-les-expositions-aux-pesticides-donnees-et-approches-geographiques.-synthese-du-seminaire-du-28-juin-2022
2023
France
technical report
fracture fixation
geographer
Respect
geography
dataset
Exhibition
pesticides
appraiser
effects of exposure to external cause, nos
pesticide, nos

---
https://www.cochrane.org/fr/CD013733/CF_les-technologies-numeriques-aident-elles-les-personnes-atteintes-de-mucoviscidose-respecter-leurs
2023
United Kingdom
review of literature
french abstract
inspiration
cystic fibrosis
administration, inhalation
cystic fibrosis
Cystic fibrosis
patient compliance
Technology
persons
disease
technology
Respect
inhalers

---
https://www.has-sante.fr/jcms/p_3404043/fr/ippsd-les-pathologies-de-l-inactivation-de-la-signalisation-pth/pthrp-anciennement-pseudohypoparathyroidies-et-maladies-associees
2023
false
false
false
France
pseudohypoparathyroidism
pseudohypoparathyroidism
practice guideline
comorbidity
pseudohypoparathyroidism

---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-27-03-2023-liptruzet-10-mg-20-mg-comprime-pellicule
2023
false
false
false
France
French
legislation
drug information
france
administration, oral
drug combinations
atorvastatin calcium
Ezetimibe
atorvastatin and ezetimibe

---
http://manuel3.cuen.fr/spip.php?rubrique8
2023
false
false
false
France
educational course
French pre-residency program examination
acid-base equilibrium
acid-base equilibrium

---
http://manuel3.cuen.fr/spip.php?rubrique9
2023
false
false
false
France
educational course
French pre-residency program examination
hypercalcemia
Hypercalcemia
hypocalcemia
Hypocalcemia
hypercalcemia
hypocalcemia

---
http://manuel3.cuen.fr/spip.php?rubrique14
2023
false
false
false
France
educational course
French pre-residency program examination
diabetic nephropathies
Diabetic nephropathy

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-neonatal-sanguin-par-spectrometrie-de-masse-en-tandem-derreurs-innees-du-metabolisme-asa-ga1-lchadd-tfpd-vlcadd.html
2023
Canada
technical report
Mass spectrometry
neonatal screening, nos
tandem mass spectrometry
metabolism, inborn errors
blood volume, nos
mass screening
aspirin
metabolic disease, nos
Metabolism
neonatal screening

---
https://www.has-sante.fr/jcms/p_3424048/fr/luzadel-calcifediol-deficit-en-vitamine-d
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
Product containing only calcifediol in oral dose form (medicinal product form)
calcifediol
evaluation of the transparency committee
vitamin d deficiency
calcifediol

---
https://www.srlf.org/REACTU/remplir-patients-choc-septique-eviter-goutte-deau-qui-fait-deborder-vase
2023
France
critical appraisal or critical reading
gout
guttate
gout, nos
Water
Water
gout
uterine artery embolization
patients
septic shock
shock, septic
water
water
has patient
Shock

---
https://ansm.sante.fr/tableau-marr/agalsidase-beta
2023
false
false
false
France
French
risk management
agalsidase beta
guidelines for drug use
patients guideline
infusions, intravenous
enzyme replacement therapy
fabry disease
continuity of patient care
home health nursing

---
https://ansm.sante.fr/tableau-marr/asfotase-alfa
2023
false
false
false
France
French
risk management
guidelines for drug use
asfotase alfa
asfotase alfa
self administration
patients guideline
child
injections, subcutaneous
enzyme replacement therapy
asfotase alfa
hypophosphatasia

---
https://ansm.sante.fr/tableau-acces-derogatoire/nexviadyme-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2023
false
false
false
France
French
summary of product characteristics
package leaflet
infusions, intravenous
Avalglucosidase Alfa
glycogen storage disease type ii
guidelines for drug use

---
http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid

---
https://ansm.sante.fr/tableau-marr/deferasirox
2023
false
false
false
France
French
administration, oral
risk management
medication errors
guidelines for drug use
patient education handout
continuity of patient care
Deferasirox

---
https://www.theses.fr/2023NORMR076
2023
France
dissertations, academic
science
Fabry Disease
fabry disease
fabry's disease

---
https://www.filiere-g2m.fr/documentation/publication/187:protocole-d-urgence-coma-et-maladies-hereditaires-du-metabolisme
2023
France
algorithms
metabolism, inborn errors
hereditary diseases
On Study
coma
emergencies
Genetic Disorder
Emergency Room
coma, nos
metabolic diseases
Emergency
coma
hereditary disease, nos
Coma
metabolic disease, nos
Urgency
Clinical Study Protocol
Metabolic Disorder

---
https://ansm.sante.fr/tableau-marr/alglucosidase-alpha
2023
false
false
false
France
French
guidelines for drug use
risk management
alpha-Glucosidases
alpha-Glucosidases
alpha-Glucosidases

---
https://www.youtube.com/watch?v=TKLbekAZrMU&list=PLXEludpb2o0QiXi5gCXNxGuMbgQbsNzGg
2023
France
congresses
audiovisual material
Metabolism
hydrogen, nos
general metabolic function, nos
hydrogen
evaluation studies as topic
energy metabolism
homo sapiens
humans

---
https://www.ors-na.org/publications/estimation-des-besoins-potentiels-en-education-therapeutique-du-patient-approche-via-la-prevalence-des-ald/
2023
France
technical report
needs
appraiser
Respect
prevalence
education
therapeutics
Treatments
patient education as topic
fructose-bisphosphate aldolase
Therapeutics
chronic disease
patient need for
health services needs and demand
adrenoleukodystrophy

---
https://ansm.sante.fr/tableau-marr/elosulfase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
elosulfase alfa
elosulfase alfa
infusions, intravenous
infusion rate
drug dosage calculations

---
https://dumas.ccsd.cnrs.fr/dumas-04061185
2023
France
Diseases
disease, nos
cystic fibrosis
cystic fibrosis
disease
Cystic fibrosis
Rare disease
rare diseases

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pombiliti
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Cipaglucosidase Alfa
Cipaglucosidase Alfa
cipaglucosidase alfa
enzyme replacement therapy
glycogen storage disease type ii
Glycogen storage disease type II late onset (disorder)
drug therapy, combination
miglustat
infusions, intravenous
pregnancy
breast feeding
drug evaluation, preclinical
adult

---
https://www.cochrane.org/fr/CD002011/CF_la-kinesitherapie-respiratoire-conventionnelle-classique-comparee-dautres-methodes-de-degagement-des
2023
United Kingdom
review of literature
french abstract
respiratory system
Other methods
disease
cystic fibrosis
cystic fibrosis
Cystic fibrosis
protestantism
respiratory tract
physical therapy specialty
persons

---
http://www.lecrat.eu/?s=Canakinumab+-+Grossesse+et+allaitement
2023
false
false
false
France
French
drug information
pregnancy
breast feeding
canakinumab

---
https://www.santepubliquefrance.fr/determinants-de-sante/climat/fortes-chaleurs-canicule/documents/rapport-synthese/estimation-de-la-fraction-de-la-mortalite-attribuable-a-l-exposition-de-la-population-generale-a-la-chaleur-en-france-metropolitaine.-application-a
2023
France
journal article
attention
France
general practitioners
Applications
french
population
General populations
Periodical
heat exposure, nos
France
france
organization and administration
Respect
Applications
mortality
hot temperature
heat
Applications
France
France
appraiser
Exhibition

---
https://www.has-sante.fr/jcms/p_3448570/fr/vimizim-elosulfase-alfa-mucopolysaccharidose-de-type-iv-a-syndrome-de-morquio-a
2023
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
elosulfase alfa
mucopolysaccharidosis type IV A
enzyme replacement therapy
evaluation of the transparency committee
mucopolysaccharidosis IV
elosulfase alfa

---
https://ansm.sante.fr/tableau-acces-derogatoire/crysvita
2023
false
false
false
France
French
drug information
burosumab
burosumab
FGF23-related hypophosphataemia
Oncogenic hypophosphatemic osteomalacia
hypophosphatemia

---
https://www.has-sante.fr/jcms/p_3451561/fr/fixical-carbonate-de-calcium-carences-calcique-et-traitement-d-appoint-de-l-osteoporose
2023
France
evaluation of the transparency committee
osteoporosis, nos
osteoporosis
calcium carbonate
deficiency state
calcium carbonate
Osteoporosis
osteoporosis
Calcium carbonate

---
https://www.ema.europa.eu/en/medicines/human/EPAR/opfolda
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
miglustat
miglustat
miglustat
drug approval
europe
adult
Glycogen storage disease due to acid maltase deficiency, late-onset
adult glycogen storage disease type II
drug therapy, combination
Cipaglucosidase Alfa
administration, oral
capsules
aged
food-drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://ansm.sante.fr/informations-de-securite/arret-de-commercialisation-de-soludactone-recommandations-de-lansm
2023
false
false
false
France
French
drug information
drug combinations
canrenoic acid
canrenoate potassium
aldosterone antagonists
diuretics
tromethamine
hypokalemia

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/ozidia-5-mg-comprime-a-liberation-prolongee-glipizide
2023
false
false
false
France
French
drug information

---
https://www.cochrane.org/fr/CD004197/CF_differentes-manieres-dadministrer-des-antibiotiques-pour-eliminer-une-infection-pseudomonas
2023
United Kingdom
review of literature
french abstract
organization and administration
cystic fibrosis
administration
pseudomonas aeruginosa
Administration
administration of antibiotic
Infectious disease
infection due to pseudomonas aeruginosa
Antibiotics
antibiotics
administrators
pseudomonas infections
mannerism
Cystic fibrosis
disease
cystic fibrosis
administrative personnel
anti-bacterial agents
persons
Pseudomonas aeruginosa Infection

---
https://www.has-sante.fr/jcms/p_3402366/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2023
false
false
false
France
vutrisiran
treatment outcome
insurance, health, reimbursement
Vutrisiran
rna, small interfering
injections, subcutaneous
adult
RNAi Therapeutics
amyloid neuropathies, familial
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related

---
https://www.has-sante.fr/jcms/p_3455973/fr/strensiq-asfotase-alfa-hypophosphatasie
2023
false
false
false
France
hypophosphatasia
treatment outcome
insurance, health, reimbursement
enzyme replacement therapy
asfotase alfa
hypophosphatasia
evaluation of the transparency committee
asfotase alfa

---
https://www.has-sante.fr/jcms/p_3455991/fr/junaliza-atorvastatine-/-ezetimibe-hypolipidemiants-en-association
2023
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
hypercholesterolemia
adult
Primary hypercholesterolemia (disorder)
atorvastatin and ezetimibe
evaluation of the transparency committee
hypolipidemic agents
drug combinations
Atorvastatin
Ezetimibe

---
https://www.has-sante.fr/jcms/p_3456145/fr/physiogine-estriol-affections-vulvo-vaginales
2023
false
false
false
France
administration, intravaginal
vaginal suppositories
insurance, health, reimbursement
estriol
estrogen replacement therapy
evaluation of the transparency committee
vaginal diseases
estriol

---
https://www.has-sante.fr/jcms/p_3456309/fr/xenpozyme-olipudase-alfa-maladie-rare
2023
false
false
false
France
infusions, intravenous
treatment outcome
insurance, health, reimbursement
olipudase alfa
enzyme replacement therapy
child
adult
orphan drug production
Acid sphingomyelinase deficiency
niemann-pick diseases
evaluation of the transparency committee
rare diseases
olipudase alfa

---
https://www.has-sante.fr/jcms/p_3456509/fr/fixical-vitamine-d3-calcium-carbonate-cholecalciferol-ou-vitamine-d3-prevention-et-correction-des-carences-vitamino-calciques
2023
false
false
false
France
evaluation of the transparency committee
vitamin d3
cholecalciferol
calcium carbonate
vitamins
calcium carbonate
Vitamin
Calcium carbonate

---
https://www.has-sante.fr/jcms/p_3456825/fr/pombiliti-cipaglucosidase-alfa-opfolda-miglustat-en-association-forme-tardive-maladie-de-pompe
2023
false
false
false
France
Cipaglucosidase Alfa
cipaglucosidase alfa
Glycogen storage disease type II late onset (disorder)
miglustat
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
miglustat
drug therapy, combination
glycogen storage disease type ii

---
https://www.ofdt.fr/publications/collections/methode/le-cout-social-des-drogues-estimation-en-france-en-2019/
2023
France
technical report
drug addicts
appraiser
cost
France
Respect
socialism
France
france
France
drugged state
drug users
french
France
costs and cost analysis

---
https://ansm.sante.fr/tableau-marr/patisiran
2023
false
false
false
France
French
risk management
patisiran
patisiran
guidelines for drug use
patisiran
infusions, intravenous
Drug-Related side effects and adverse reactions
patient education handout
Adverse reaction caused by drug or medicament administered by infusion (disorder)
Infusion Site Reaction
Infusion Site Reaction
signs and symptoms

---
https://aurore.unilim.fr/theses/nxfile/default/47e35dbd-c7b2-446e-b18a-4cd433b742e5/blobholder:0/M20233122.pdf
2023
France
dissertations, academic
Reviewing
obstruction, nos
association
Relationship
Obstruction
Metabolic Syndrome
general metabolic function, nos
Metabolic Syndrome
metabolism
review literature as topic

---
https://dumas.ccsd.cnrs.fr/dumas-04142148
2023
France
dissertations, academic
hereditary diseases
cardiomyopathies
hereditary disease, nos
metabolic disease, nos
dilated cardiomyopathy secondary to metabolic disorder
Metabolic Disorder
metabolic diseases
Genetic Disorder
Cardiomyopathy
metabolism, inborn errors

---
https://www.inserm.fr/dossier/hemochromatose-genetique/
2023
France
scientific and technical information
gene, nos
hemochromatosis
genetics
Hereditary Hemochromatosis
hemochromatosis, nos
Population Genetics
Cancer Genetics
Gene Therapy

---
https://www.sfm-microbiologie.org/actualites/transport-de-matieres-infectieuses-et-agents-biologiques-du-reb/
2023
France
scientific and technical information
Infectious Agent
biology
Transfer
Carrying
Transport Process
biology
biological transport, nos
hazardous substances
Transportation
biological transport
Biological Agent
Transport Device
biological products
biological agent, nos
risk
Biological Therapy
infectious agent, nos
epidemics
GDC Procedures Performed Terminology
Epidemic Disorder
Delivery

---
https://sesstim.univ-amu.fr/fr/content/estimation-et-intervalle-de-confiance
2023
France
educational course
Respect
Estimate
Statistical Estimation
confidence intervals
Confidence Interval
appraiser

---
https://ansm.sante.fr/informations-de-securite/prise-en-charge-par-colchicine-de-la-goutte-une-nouvelle-posologie-plus-faible-et-un-message-dalerte-sur-les-boites-pour-reduire-le-risque-de-surdosage
2023
false
false
false
France
French
risk management
colchicine
colchicine
gout
guidelines for drug use
gout suppressants
gout suppressants
colchicine

---
https://ansm.sante.fr/tableau-marr/imiglucerase
2023
false
false
false
France
French
guidelines for drug use
risk management
imiglucerase
imiglucerase
infusions, intravenous
enzyme replacement therapy
home nursing
gaucher disease
home infusion therapy
home infusion therapy

---
https://ansm.sante.fr/actualites/retour-dinformation-sur-le-prac-doctobre-2023-25-28-septembre
2023
false
false
false
France
French
pharmacovigilance note
product surveillance, postmarketing
Omacor
omega-3-triglycerides incl. other esters and acids
atrial fibrillation
omega-3 ethyl ester 90

---
https://www.has-sante.fr/jcms/p_3467298/fr/nexviadyme-avalglucosidase-alfa-maladie-de-pompe
2023
false
false
false
France
enzyme replacement therapy
treatment outcome
insurance, health, reimbursement
avalglucosidase alfa
adult
adolescent
child
guidelines for drug use
infusions, intravenous
evaluation of the transparency committee
glycogen storage disease type ii
Avalglucosidase Alfa

---
https://www.cochrane.org/fr/CD015236/CF_prebiotiques-pour-les-personnes-atteintes-de-mucoviscidose
2023
United Kingdom
review of literature
french abstract
prebiotics
People
Cystic Fibrosis
cystic fibrosis
disease
persons
cystic fibrosis

---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/soludactone-100-mg-et-200-mg-lyophilisat-et-solution-pour-usage-parenteral-canrenoate-de-potassium-trometamol
2023
false
false
false
France
French
drug information
summary of product characteristics

---
https://www.has-sante.fr/jcms/p_3470276/fr/pombiliti-cipaglucosidase-alfa-/-opfolda-miglustat-forme-tardive-de-la-maladie-de-pompe
2023
false
false
false
France
Glycogen storage disease type II late onset (disorder)
treatment outcome
insurance, health, reimbursement
drug therapy, combination
enzyme replacement therapy
adult
cipaglucosidase alfa
infusions, intravenous
administration, oral
miglustat
evaluation of the transparency committee
miglustat
glycogen storage disease type ii
Cipaglucosidase Alfa

---
https://ansm.sante.fr/informations-de-securite/ferrostrane-0-68-pour-cent-sirop-feredetate-de-sodium-risque-derreur-medicamenteuse-chez-les-nourrissons-de-faible-poids
2023
false
false
false
France
French
pharmacovigilance note
ferric sodium edetate
infant
infant, low birth weight
medication errors

---
https://www.has-sante.fr/jcms/p_3471816/fr/suvreza-rosuvastatine-calcique/ezetimibe-hypercholesterolemie
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
Ezetimibe
Rosuvastatin Calcium
anticholesteremic agents
hydroxymethylglutaryl-coa reductase inhibitors
administration, oral
rosuvastatin and ezetimibe
adult
hypercholesterolemia
Primary hypercholesterolemia (disorder)
Familial hypercholesterolemia - heterozygous (disorder)
evaluation of the transparency committee

---
https://www.has-sante.fr/jcms/p_3474022/fr/skyclarys-omaveloxolone-traitement-de-l-ataxie-de-friedreich-af
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Omaveloxolone
adult
adolescent
guidelines for drug use
administration, oral
capsules
omaveloxolone
evaluation of the transparency committee
friedreich ataxia

---
https://www.cochrane.org/fr/CD011624/PREG_quelle-est-la-fourchette-de-glycemie-la-plus-efficace-pour-guider-le-traitement-des-femmes-qui
2023
United Kingdom
review of literature
french abstract
Execution
Range
women
gestational diabetes mellitus, nos
Analytical Procedure Range
CDISC SDTM Diabetes Therapy Terminology
Pregnancy
Blood Glucose
blood glucose
No Treatment for Diabetes
Diabetes Therapy
Sample Range
What Month is it
Blood Glucose Measurement
Gestational Diabetes
Protocol Treatment Course
diabetes, gestational
pregnancy in diabetics
Until Effective
Woman
Pregnant
pregnancy, nos

---
https://sesstim.univ-amu.fr/fr/video-box/webinar-quantim-mathilde-pascal
2023
France
audiovisual aids
CHFR Gene
heat
Respect
Exposure
Estimate
heat exposure, nos
france
mortality
Exhibition
french
Warmth
Heater Device
Cell Fraction
appraiser
Exposure Domain
Attribution
Statistical Estimation
hot temperature

---
https://ansm.sante.fr/actualites/diabete-de-type-2-et-tensions-dapprovisionnement-conduite-a-tenir-pour-la-prescription-des-analogues-de-glp1
2023
false
false
false
France
French
incretins
Glucagon-Like Peptide-1 Receptor
guideline
semaglutide
semaglutide
continuity of patient care
hypoglycemic agents
diabetes mellitus, type 2
guidelines for drug use
Liraglutide
break in supply
liraglutide

---
https://www.has-sante.fr/jcms/p_3478088/fr/galafold-chlorhydrate-de-migalastat-deficit-en-a-galactosidase-a
2023
false
false
false
France
fabry disease
adolescent
evaluation of the transparency committee
migalastat hydrochloride
migalastat
Migalastat Hydrochloride
galactosidases

---
https://www150.statcan.gc.ca/n1/pub/82-003-x/2023012/article/00002-fra.htm
2023
Canada
journal article
Cancer Registry
No Information Available
Statistical Estimation
dataset
appraiser
registers
Respect
Data
Established
survival
What Month is it
neoplasm, malignant
cancer
Data Set
Estimate
neoplasms

---
https://www.has-sante.fr/jcms/p_3482344/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine
2023
false
false
false
France
RNAi Therapeutics
treatment outcome
insurance, health, reimbursement
vutrisiran
injections, subcutaneous
amyloid neuropathies, familial
adult
polyneuropathies
evaluation of the transparency committee
amyloidosis, hereditary, Transthyretin-Related
Vutrisiran

---
https://dumas.ccsd.cnrs.fr/dumas-04358501
2023
France
dissertations, academic
adult
prediabetes
Charge
review literature as topic
Reviewing
Legal Adult
patient care management
adulthood
narration
Family Practice
proposita
prediabetic state
general practice
family practice
Prediabetes
Biomedicine
population
General Population

---
https://www.medix.ch/media/patienteninformation_ferinject_frz._2021_8.6.21_mh.pdf
2023
Switzerland
patient education handout
Perfusion
Iron
iron
perfusion
FER Gene
Dietary Iron
Infusion Procedure
iron, nos
Ferric Carboxymaltose Solution
Infusion Method of Administration
Ferinject
Iron Measurement
Chemotherapeutic Perfusion
perfusion, nos

---
https://www.medix.ch/fr/connaissances/guide-des-bonnes-pratiques/carence-en-fer/
2023
Switzerland
practice guideline
iron deficiency, nos
Iron Deficiency
iron deficiency
iron

---
Nous contacter.
30/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.